The MHC class II gene Aa was disrupted by targeted mutation In embryonic stem (ES) cells derived from C57BL/6 mice to prevent expression of MHC class II molecules. Contrary to previous reports, the effect of the null-mutation on T cell development was Investigated In C57BL/6 mice, which provide a defined genetic background. The complete lack of cell surface expression of MHC class II molecules In B6-Aa°IAa° homozygous mutant mice was directly demonstrated by cytofluorometrlc analysis using antl-A b and anti-la specific mAbs. Development of CD4 + CD8" T cells In the thymus was largely absent except for a small population of thymocytes expressing high levels of CD4 together with low amounts of CDS. The majority of these cells express the TCR at high density. Although mature CD4+CD8~ T cells were undetectable In the thymus, some T cells with a CD4 + CD8~TCR hlBh phenotype were found In lymph nodes and spleen. Peripheral T cells from the mutant mice can be polyclonally activated In vitro with the mltogen concanavalln A. However, they could not be stimulated with staphylococcal enterotoxln B In autologous lymphocyte reactions, thereby demonstrating the absence of MHC class II expression in these mice. Peripheral B cells In B6-A8°/Aa° mutants were functional and responded to the T cell independent antigen levan by the production of antigenspecific IgM antibodies similar to wild-type cells. The B6-Aa°IAa° mutant mice described In this study represent an important tool to Investigate the Involvement of MHC class II molecules in lymphocyte maturation and the Immune response.
Introduction
Transgenic mouse lines expressing different a/3 TCR have revealed that the specificity of the TCR for either MHC class I or class II molecules directs the development of immature CD4 + CD8 + thymocytes to either CD4 + CD8~ or CD4"CD8 + mature T cells (1 -5) . The central role of MHC molecules in the development and function of lymphocytes has also been addressed in MHC class I and MHC class ll-deficient mice generated by targeted mutation (6) (7) (8) (9) . In mice of H-2 b haplotype, a naturally occurring mutation in the Ea promoter region blocks the expression of Ea genes, and leads to the lack of EctEfi heterodimers on the surface of thymic epithelial cells, dendritic cells, macrophages, and B cells (10) . Cosgrove etal.
(8) and Grusby etal. (9) disrupted the Ab gene in 129/Sv mice and investigated the effect of the inactivation in 129/Sv x C57BL/6 hybrids. They found a severe reduction in the development of mature CD4 + CD8~ T cells in the thymus of these mice. In the periphery, CD4 + CD8" T cells accumulated to -1/10 of the normal amount. Peripheral T cells from mutant mice showed normal proliferative responses to the mitogen concanavalin A (Con A). In addition, mutant mice mounted a normal antigen-specific IgM response to haptenated ovalbumin, but were unable to switch to IgG isotypes (9) . The Ig isotype profile after immunization with the T cell independent antigen levan, however, was normal (8) .
The MHC class II deficient mice generated thus far could potentially express AaEjS heterodimers which may select CD4 + T cells. To exlcude the possible surface expression of AaE/S heterodimers of mixed isotypes, we introduced a null-mutation in the Aa, rather than in the Ab gene. We report here the first targeted mutation in C57BL/6 mice by homologous recombination in embryonic stem (ES) cells derived from this strain. Germ line competence of another ES cell line derived from C57BL/6 was recently demonstrated, but no gene targeting has been reported yet (11) . C57BL/6 mice are immunologically well characterized, and a large variety of mutations affecting the immune system are known in this strain. MHC class II deficient B6-Aa°IAa° mice will facilitate investigation of the various roles of MHC class II molecules in lymphocyte maturation, T-B cell interaction, and antigen presentation in the normal and diseased state.
Here we show that T cell development in B6-Aa°/Aa° mice is severely impaired. No mature CD4+CD8" T cells were detectable in the mutant thymus, whereas CD4 + CD8 low cells appeared at normal frequencies even in the absence of MHC class II expression. Peripheral T cells responded normally to the mitogen Con A. They were, however, largely unresponsive to the staphylococcal enterotoxin B (SEB) superantigen using autoiogous spienocytes as presenting cells, which demonstrates the absence of classical MHC class II expression in these mice.
Methods

Construction of the targeting vector
The cosmid clone A019 containing the Aa ti allele was obtained from E. Weiss (University of Munich, Germany). The replacement vector for gene targeting was constructed from a 4.0 kb BamH\-Xbal fragment by insertion of a PGKneo poly(A) + cassette (12, 13) into the H/ndlll site of the second exon encoding the a1 domain of the Aa chain (Fig. 1) . This disrupts the coding sequence of the gene and creates a null-mutation. The HSV-tfc gene used for negative selection was added 5' to the fragment.
Gene targeting in C57BLJ6 embryonic stem cells
ES cells were derived from mouse strain C57BL/6-77iy7.1 (14) . They were grown on 3000 rad irradiated primary embryonic feeder cells derived from strain CD1 -MTKneo2 transgenic for the neomycin resistance gene (15) and 100 U/ml LIF. The culture medium was based on Dulbecco's minimal essential medium supplemented with 15% FCS, 2 mM glutamine, 1 x non-essential amino acids, 0.1 mM )S-mercaptoethanol, and 100 U/ml penicillin-streptomycin. The targeting vector was linearized by Cla\ digestion. Approximately 5 x 10 7 ES cells were transfected by electroporation at 250 V/500 /*F in a BioRad gene pulser and plated on five 6 cm gelatinized dishes containing neomycin resistant embryonic feeder cells. Transfectants were positively selected with 350/ig/ml Geneticin (G418 Gibco, Paisley, UK) starting at day 1 after electroporation and negatively with 0.2 nM FIAU (Oclassen, San Rafael, CA) after 3 days in culture. Resistant clones were picked and expanded in 48-well plates (16) . shown). Homologous integration occurred in two out of 480 clones screened. One of these clones, Bruce 4.1, was used for further experiments.
Generation of germ line chimeras and homozygous mutant offspring
Microinjection of ES cells into blastocysts was performed essentially as described (17) . Blastocysts were collected from BALB/c females at day 4 of pregnancy in CZB medium (18) . ES cell cultures were trypsinized and transferred to gelatinized 6 cm dishes. Feeder cells were allowed to attach to the culture dish for 1 h and then loosely adherent ES cells were removed by gentle pipetting. About 15 ES cells were injected per blastocyst. Mutant stem cells from clone Bruce 4.1 were injected into 283 blastocysts, which were reimplanted into B6CBAF1 foster mothers. Fifty-two offspring were born, 23 of which were chimeric as revealed by their mosaic coat colour. Ten chimeric males were bred with C57BU6 females and five transmitted the mutation to the offspring as determined by PCR and Southern blot analysis (not shown). Digestion of DNA with SamHI and subsequent hybridization of the blot with a 600 bp Xba\ -EcoRI probe specific for exons 4 and 5 revealed a 3.1 kb band indicative of the mutant allele, in addition to the 5.5 kb band derived from the wild-type allele. Heterozygous mutant offspring (B6-Aa°l+) were interbred to establish the new strain B6-Aa°/Aa° homozygous for the nullmutation in the Aa gene.
Cytofluorometric analysis
Lymphocytes were analysed after fluorescent labelling with a FACScan flow cytometer (Becton-Dickinson, Mountain View, CA) as described previously (19) . Briefly, thymus and lymph nodes homogenized, and the cells were recovered and washed twice in PBS, 4% FCS, 0.1% NaN 3 at 4°C. About 5 x 10 5 cells per sample were stained in the same buffer with optimal concentrations of antibodies. The following antibodies were used: antimouse CD4 -phycoerythrin (Becton-Dickinson), anti-mouse CD8-FITC (Becton-Dickinson), anti-mouse CD3e-biotin, antimouse a/STCR -biotin, anti-mouse heat stable antigen (HSA) biotin, anti-mouse Pgp-1-biotin, anti-mouse I-A b -biotin (AF6-120.1), anfj-mouse laPWwsJ_biotin (7-16.17), anrj |-E dk *'-bkrtin (AMS-16), all from PharMingen, San Diego, CA; anti-mouse TCR V (B20.6.5, (20)), anti-mouse TCR V^3 (KJ25a, (21) (25)).
MHC class ll-deficient C57BU6 mice 959
Secondary reagents were FITCMabelled anti-mouse Ig, and FITClabelled anti-rat Ig (Silenus Laboratories, Victoria, Australia) or Streptavidin-Cy-Chrome (PharMingen). T cell independent immune responses B6-Aa°IAa° mutant mice and age and sex matched C57BL/6 control mice were immunized by intraperitoneal injection of 100 ng levan dissolved in 100 y\ PBS (Sigma). Mice were bled at day 5 and day 10 by retro-orbital puncture and IgM titres in the serum determined by ELISA. For this assay microtiter plates were coated overnight at 4°C with 20 ^g/ml levan in PBS. After two washing steps with PBS, 0.1 % Tween 20, wells were blocked for 2 h with 1% BSA, 0.1% Tween 20 in PBS, washed again, and incubated with serial dilutions of serum samples in PBS, 1% BSA, 0.1% Tween 20 for 2 h. Wells were washed five times, incubated with 100 /J (500 ng) goat anti-mouse affinity-purified antj-^ chain Ig fraction conjugated to alkaline phosphatase in PBS, 1% BSA for 1 h and washed again. Enzymatic reaction was started by addition of 200 /J 0.4 mg/ml paranitrophenylphosphate in diethanolamine buffer, pH 9.8, and the optical density was measured at 405 nm.
In vitro stimulation of splenocytes
Results
MHC class II molecules are not expressed in B6-Aa°/Aa° mice as revealed by FACS analysis
In B6-Aa°IAa° mutant mice, thymi and lymph nodes were normal or somewhat enlarged and contained slightly higher numbers of thymocytes and lymphocytes respectively (Table 1) .
To investigate MHC class II expression in normal C57BL/6 and mutant B6-Aa°IAa° mice, B lymphocytes were stained with antibodies specific for AaA/3 and Eo£0 heterodimers and analysed by flow cytometry. As expected, B cells from normal C57BL/6 mice, which carry a defective Ea gene, could be stained only with anti-A b and anti-la antibodies (Fig. 2 ), but not with anti-E antibodies (not shown). B cells from homozygous mutants, however, gave only background staining with any of these anti- bodies. This shows that disruption of the Aa gene indeed blocked the expression of AaA0 heterodimers in these mice. The virtually complete absence of MHC class II expression in B6-Aa°/Aa°m utants was confirmed by a functional assay using SEB (see below).
Phenotype of thymocytes
The consequences of MHC II deficiency in B6-Aa°/Aa° mutant mice for the development of thymocytes were analysed using mAbs specific for different developmental^ regulated surface molecules. Virtually no CD4 + CD8" T cells could be detected in the mutant thymus as opposed to ~3% in the control (Fig. 3a) . However, a CD4+CD8 10 * population could be discerned, which comprised about 2% of the total number of thymocytes, comparable to wild-type mice. CD4 + CD8 + , CD4-CD8+, and CD4"CD8" thymocytes occur at normal frequencies in B6-Aa°IAa° mice. In mutant mice, the CD4 + CD8 + cells show a 1.7-fokj higher surface expression of CD4 compared with normal thymocytes (not shown). A similar increase was found in the CD4+CD8 10 " population of the mutant. Surface expression of CD8 in these cells is only slightly increased.
The number of TCR hi°h expressing cells is normally low, i.e. -8% in normal mice and reduced slightly to ~6% in mutant mice (Fig. 3b) . However, the distribution of TCR"" 11 expressing cells in thymocyte subpopulations was changed in class II deficient mice. There was an increase of TCR^ cells from 1.9 to 3% in the CD4 + CD8 + population (Fig. 3c ). CD4+CD8 1 "* cells in both normaJ and mutant mice were mostty TCR^ expressing thymocytes. Expression of the Pgp-1 antigen on the cell surface of thymocytes changes during development and was found to be highest on medullary thymocytes (26) . Cytofluorometric analysis revealed that Pgp-1 hl°h expressing cells were diminished by a factor of -2 in B6-Aa°/Aa° mutants (not shown). The expression level of another developmentally regulated surface molecule on thymocytes, the HSA, was not influenced by the Aa° mutation.
Phenotypes of lymphocytes
As in the thymus, the composition of T cell subpopulations in peripheral lymphatic organs of B6-Aa°IAa° mutant mice was drastically different from normal mice. Only -4% CD4 + CD8T cells could be detected in the lymph nodes of mutant mice compared with ~60% in control mice. This strong reduction was accompanied by an increase in both relative and absolute numbers of CD4~CD8 + T cells (Fig. 4) . Lymph node T cells from mutant mice consist almost entirely (-90%) of CD8 single positive cells. The expression level of both CD4 and CD8 molecules appeared to be normal. The remaining CD4 + CD8" T cells in mutant mice were polyclonal in origin and expressed an apparently normal TCR V e repertoire ( Table 2) .
Functional analysis of splenocytes
Functionality of splenocytes from B6-Aa°IAa° mice was investigated by proliferation assays. With the T cell mitogen Con A, variable responses were induced; however, these did not differ significantly from control experiments (not shown). The superantigen SEB caused strong proliferation of wild-type splenocytes, while mutant T cells practically did not respond in several independent autologous mixed lymphocyte reactions. Proliferation was found to be 25 times lower compared with the control and reached only about twice the background level obtained with medium alone (Fig. 5a) unresponsiveness to SEB of spleen cells from mutant mice is expected based on the deficiency of classical MHC class II expression in them. The bacterial toxin LPS, a B cell mitogen, had the same effect on mutant as on normal splenocytes.
Immunization with T cell independent antigen
Protein antigens must be presented as peptide fragments by MHC class II molecules on antigen presenting cells in order to elicit an immune response. T cell independent antigens, however, normally polymeric molecules with repeated epitopes, stimulate B lymphocytes directly by cross-linking their Ig receptors. When mutant mice were immunized with the T cell independent anti-CD4 60 y.
B6.Aa°/Aa°C + CD8~ T cells were reduced from 60 to 4% in mutant mice, whereas CD4~CD8 + T cells were increased from 37 to 89%. gen levan, they responded with a normal increase in antigenspecific IgM titers (Fig. 5b) .
Discussion
MHC class II molecules are expressed as AaA/3 and EaE0 heterodimers on the cell surface of thymic epithelial cells, dendritic cells, macrophages, and B cells in the mouse. Heterodimers of mixed isotypes were identified in vivo only for the d-haplotype. Ruberti etal. (27) found that A^Ec/ 1 heterodimers played a major role in the immune response of normal mice towards a peptide from sperm whale myoglobin. In in vitro transfection experiments, formation of A/3Ea heterodimers, but not the reciprocal AaE/3 complexes, has been observed in several laboratories (28) (29) (30) (31) . To generate a mouse strain with no expression of classical MHC class II molecules, lacking even the hypothetical heterodimers of mixed isotypes, we chose to inactivate the Aa gene, rather than the Ab gene, in mice of H-2 b haplotype. Absence of AaA/3 expression in B6-Aa°IAa° mutant mice was demonstrated by cytofluorometry with two different mAbs. This result was confirmed by a highly sensitive analysis of MHC class II expression using the superantigen SEB in a functional assay. SEB is a very potent stimulator of T cells based on its ability to cross-link MHC class II molecules with certain Vê lements. T cells from B6-Aa°IAa° mutant mice were almost completely unresponsive to stimulation with SEB using autologous splenocytes as presenting cells, but did respond to the mitogen Con A, which induces proliferation by direct binding to mitogen receptors on T cells. The very low remaining inducibility by SEB may indicate the presence of other MHC class ll-like molecules (37) .
The central role of MHC class II molecules for the development of CD4 + CD8" T cells has been confirmed in experiments with transgenic (4,5) and knock-out mouse strains (8, 9) . We have also found an up-regulation of CD4 expression in CD4 + CD8 + thymocytes in mutant mice, as observed previously by Cosgrove et al. (8) . The avidity of thymocyte interaction with MHC molecules on stromal cells during maturation is determined by contributions from both the a/3 TCR and the coreceptor molecules. Lack of TCR-MHC class II interaction in B6-Aa°IAa° mutants may lead to an up-regulation of CD4 expression on thymocytes to compensate for this deficiency. Alternatively, TCR-MHC class II interaction may be needed to limit CD4 expression in CD4 + CD8 + thymocytes. This explanation is supported by the Numbers give percentages of T ceBs in the CD4 + or CD8 + population expressing the indicated V fl TCR region. Data were obtained by three-colour cytofluorometric analysis with anti-CD4, anti-CD8, and different anti-V^ antibodies. Values for vyi, VpH, and V»12 expressing T ceBs were summarized. No significant difference between mutant and control mice in V fl expression by CD4+ T cete was identified. recent identification of a TCR-induced post-transcriptional regulation of the level of CD4 and CD8 messenger RNAs in early thymocytes (32) .
We have detected a relative increase in the number of a/3 jQphioh expressing CD4 + CD8 + thymocytes in mutant mice, but no increase in their level of TCR expression, contrary to what was reported in Ab°IAb° mutant mice by Cosgrove era/. (8) . In vivo experiments using anti-MHC class II antibodies also showed no up-regulation of TCR levels on thymocytes (33, 34) .
We have identified a distinct population of CtM^^DS 10 
Although CD4
+ CD8" were undetectable in the thymus of B6-Aa°IAa° mice, they appear at low frequency in the periphery. These cells were shown to be polyclonal in origin by their heterogeneous TCR V^ repertoire. Similar observations were made previously in Ab°IAb° class II knock-out mice (8, 9) . We can now exclude that these cells had matured by interaction of their TCR with AaE/3 heterodimers of mixed isotypes, since these heterodimers are absent in our Aa°/Aa° class II mutant mice. They may, however, be restricted to the novel MHC class II H-20 molecules. Alternatively, the remaining CD4 + CD8~ cells may represent cells that have not been positively selected at all, but were able to escape programmed cell death. The other possibility-mentioned already above for the development of CD4 + CD8 bw thymocytes-is that CD4 + CD8~ T cells from the mutant are in fact MHC class I restricted and have retained an inappropriate coreceptor molecule because the affinity of the TCR alone determined the pathway of differentiation. These cells would be expected to perform cytotoxic rather than helper functions despite their CD4 expression. Indeed, T cell help for Ig class switch was absent in MHC class II deficient mice after challenge with a T cell dependent antigen (9) . B cells from mutant are functional, however, as shown by their normal responses to the T cell independent antigen levan.
We have observed a 2-fold reduction of Pgp-I" 0 * 1 expressing thymocytes in the mutant. Such cells are found mainly in the medulla of the thymus (26) . Thus it appears that development of Pgp-1 hiBh expressing thymocytes may be controlled by interaction with MHC class II molecules.
MHC class II deficient B6-Aa°IAa° mice provide a useful tool to study the central role of MHC class II molecules in autoimmune diseases, allergies, and allograft reactions.
In addition, reconstitution experiments of B6-Aa°IAa° mice with different MHC class II expressing isogenic cells may reveal their involvement as antigen presenting cells in immune responses.
